Alternative splicing of GSDMB modulates killer lymphocyte–triggered pyroptosis
Science Immunology · 14.04.2023 · 8 (82)
DOI: 10.1126/sciimmunol.adg3196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 14.04.2023. Verfasst von Qing Kong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. Hauptthemen laut MEDLINE: Alternative Splicing, Pyroptosis. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Howard Hughes Medical Institute, NIAID NIH HHS.
Abstract (Originalsprache)
Granzyme A from killer lymphocytes cleaves gasdermin B (GSDMB) and triggers pyroptosis in targeted human tumor cells, eliciting antitumor immunity. However, GSDMB has a controversial role in pyroptosis and has been linked to both anti- and protumor functions. Here, we found that GSDMB splicing variants are functionally distinct. Cleaved N-terminal (NT) fragments of GSDMB isoforms 3 and 4 caused pyroptosis, but isoforms 1, 2, and 5 did not. The nonfunctional isoforms have a deleted or modified exon 6 and therefore lack a stable belt motif. The belt likely contributes to the insertion of oligomeric GSDMB-NTs into the membrane. Consistently, noncytotoxic GSDMB-NTs blocked pyroptosis caused by cytotoxic GSDMB-NTs in a dominant-negative manner. Upon natural killer (NK) cell attack, GSDMB3-expressing cells died by pyroptosis, whereas GSDMB4-expressing cells died by mixed pyroptosis and apoptosis, and GSDMB1/2-expressing cells died only by apoptosis. GSDMB4 partially resisted NK cell-triggered cleavage, suggesting that only GSDMB3 is fully functional. GSDMB1-3 were the most abundant isoforms in the tested tumor cell lines and were similarly induced by interferon-γ and the chemotherapy drug methotrexate. Expression of cytotoxic GSDMB3/4 isoforms, but not GSDMB1/2 isoforms that are frequently up-regulated in tumors, was associated with better outcomes in bladder and cervical cancers, suggesting that GSDMB3/4-mediated pyroptosis was protective in those tumors. Our study indicates that tumors may block and evade killer cell-triggered pyroptosis by generating noncytotoxic GSDMB isoforms. Therefore, therapeutics that favor the production of cytotoxic GSDMB isoforms by alternative splicing may improve antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
- Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125, USA.
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, University of Texas at Austin, Austin, TX 78712, USA.
- Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA 30602, USA.
- Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.
ORCID-Profile: Qing Kong, Shiyu Xia, Xingxin Pan, Kaixiong Ye, Haoyan Li, Xiaoqiang Tang, Nidhi Sahni, S Stephen Yi, Xing Liu, Hao Wu, Michael B Elowitz, Judy Lieberman, Zhibin Zhang
Förderung
- NCI NIH HHS
- Howard Hughes Medical Institute
- NIAID NIH HHS
- NIGMS NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Kong, Q., Xia, S., Pan, X., Ye, K., Li, Z., Li, H., Tang, X., Sahni, N., Yi, S. S., Liu, X., Wu, H., Elowitz, M. B., Lieberman, J., & Zhang, Z. (2023). Alternative splicing of GSDMB modulates killer lymphocyte–triggered pyroptosis. Science Immunology, 8(82). https://doi.org/10.1126/sciimmunol.adg3196
Vancouver
Kong Q, Xia S, Pan X, Ye K, Li Z, Li H, et al. Alternative splicing of GSDMB modulates killer lymphocyte–triggered pyroptosis. Science Immunology. 2023;8(82). doi:10.1126/sciimmunol.adg3196
BibTeX
@article{Kong2023,
author = {Kong, Qing and Xia, Shiyu and Pan, Xingxin and Ye, Kaixiong and Li, Zhouyihan and Li, Haoyan and Tang, Xiaoqiang and Sahni, Nidhi and Yi, S Stephen and Liu, Xing and Wu, Hao and Elowitz, Michael B and Lieberman, Judy and Zhang, Zhibin},
title = {Alternative splicing of GSDMB modulates killer lymphocyte–triggered pyroptosis},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {82},
doi = {10.1126/sciimmunol.adg3196}
}
EUVIMED